Swedish Orphan Biovitrum AB (publ) (SOBI.ST)
SEK 310.4
(-0.06%)
SEK 310.4
(-0.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 22.12 Billion | 18.79 Billion | 15.52 Billion | 15.26 Billion | 14.24 Billion | 9.13 Billion |
| Cost of Revenue | 8.07 Billion | 4.77 Billion | 3.48 Billion | 3.22 Billion | 3.33 Billion | 2.41 Billion |
| Gross Profit | 14.05 Billion | 14.01 Billion | 12.04 Billion | 12.03 Billion | 10.91 Billion | 6.72 Billion |
| Operating Expenses | 9.39 Billion | 10.16 Billion | 8.25 Billion | 7.57 Billion | 6.41 Billion | 3.59 Billion |
| Selling, General and Administrative Expenses | 6.67 Billion | 7.84 Billion | 6.29 Billion | 5.98 Billion | 4.93 Billion | 2.51 Billion |
| Research and Development Expenses | 2.71 Billion | 2.35 Billion | 1.99 Billion | 1.59 Billion | 1.49 Billion | 1.09 Billion |
| Other Expenses | - | -32 Million | -30 Million | -2 Million | -16 Million | -2.13 Million |
| Cost and Expenses | 17.46 Billion | 14.94 Billion | 11.74 Billion | 10.79 Billion | 9.74 Billion | 6.01 Billion |
| Operating Income | 4.65 Billion | 3.81 Billion | 3.73 Billion | 4.81 Billion | 4.53 Billion | 3.12 Billion |
| Interest Expense | 1.11 Billion | 458 Million | 419 Million | 454 Million | 241 Million | 56.46 Million |
| Income Tax Expense | 546 Million | 683 Million | 616 Million | 972 Million | 942 Million | 663.94 Million |
| Earnings before Tax | 2.95 Billion | 3.32 Billion | 3.29 Billion | 4.21 Billion | 4.24 Billion | 3.08 Billion |
| Net Income | 2.4 Billion | 2.63 Billion | 2.67 Billion | 3.24 Billion | 3.3 Billion | 2.41 Billion |
| Earnings Per Share Basic | 7.47 | 8.52 | 8.67 | 10.52 | 10.78 | 8.93 |
| Earnings Per Share Diluted | 7.39 | 8.44 | 8.62 | 10.41 | 10.72 | 8.93 |
| Weighted Average Shares Outstanding | 322.65 Million | 309.47 Million | 308.89 Million | 308.48 Million | 306.38 Million | 270.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 325.96 Million | 312.45 Million | 310.72 Million | 311.6 Million | 308.35 Million | 270.6 Million |
| Gross Margin | 0.64 | 0.75 | 0.78 | 0.79 | 0.77 | 0.74 |
| EBIT Margin | 0.33 | 0.33 | 0.37 | 0.41 | 0.42 | 0.40 |
| Profit Margin | 0.11 | 0.14 | 0.17 | 0.21 | 0.23 | 0.26 |
| EBITDA | 7.23 Billion | 6.05 Billion | 5.71 Billion | 6.72 Billion | 6.01 Billion | 3.62 Billion |
| Earnings Before Tax Margin | 0.21 | 0.20 | 0.24 | 0.32 | 0.32 | 0.34 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 6.89 Billion | 5.44 Billion | 6.25 Billion | 22.12 Billion | 6.84 Billion | 5.16 Billion |
| Cost of Revenue | 1.33 Billion | 2.14 Billion | 1.54 Billion | 8.07 Billion | 2.38 Billion | 1.16 Billion |
| Gross Profit | 5.56 Billion | 3.29 Billion | 4.7 Billion | 14.05 Billion | 4.45 Billion | 4 Billion |
| Operating Expenses | 3.52 Billion | 2.65 Billion | 3.39 Billion | 9.39 Billion | 2.85 Billion | 3.45 Billion |
| Selling, General and Administrative Expenses | 1.8 Billion | 1.75 Billion | 2.57 Billion | - | 2.07 Billion | 2.66 Billion |
| Research and Development Expenses | 845 Million | 898 Million | 814 Million | - | 777 Million | 746 Million |
| Other Expenses | 870 Million | -3 Million | - | - | - | - |
| Cost and Expenses | 4.85 Billion | 4.8 Billion | 4.94 Billion | 17.46 Billion | 5.24 Billion | 4.62 Billion |
| Operating Income | 2.03 Billion | 640 Million | 1.31 Billion | 4.65 Billion | 1.6 Billion | 547 Million |
| Interest Expense | 326 Million | 337 Million | - | 1.11 Billion | - | 431 Million |
| Income Tax Expense | 248 Million | 51 Million | 182 Million | 545 Million | 211 Million | 22 Million |
| Earnings before Tax | 1.71 Billion | 275 Million | 982 Million | 2.95 Billion | 1.23 Billion | 116 Million |
| Net Income | 1.46 Billion | 224 Million | 800 Million | 2.4 Billion | 1.02 Billion | 94 Million |
| Earnings Per Share Basic | 4.27 | 0.66 | 2.35 | - | 3.02 | 0.30 |
| Earnings Per Share Diluted | 4.22 | 0.65 | 2.33 | - | 2.99 | 0.29 |
| Weighted Average Shares Outstanding | 343.01 Million | 340.59 Million | 339.82 Million | 322.65 Million | 339.57 Million | 315.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 346.84 Million | 344.74 Million | 344.06 Million | 325.96 Million | 342.87 Million | 318.79 Million |
| Gross Margin | 0.81 | 0.61 | 0.75 | 0.64 | 0.65 | 0.77 |
| EBIT Margin | 0.43 | 0.29 | 0.36 | - | 0.38 | 0.29 |
| Profit Margin | 0.21 | 0.04 | 0.13 | 0.11 | 0.15 | 0.02 |
| EBITDA | 2.96 Billion | 1.55 Billion | 2.22 Billion | - | 2.6 Billion | 1.48 Billion |
| Earnings Before Tax Margin | 0.30 | 0.12 | 0.21 | 0.21 | 0.23 | 0.11 |
0KTI
DE
PRFT
5940
AWL
8928